Dalmia Healthcare Starts Clinical Trial with its Ayurvedic Composition to Treat COVID-19
Dalmia Healthcare, the healthcare division of Dalmia Group led by renowned industrialist Sanjay Dalmia, starts clinical trial to evaluate the efficacy and safety of polyherbal combination “Astha-15” for treatment of COVID-19. The Dalmia Centre for Research and Development (DCRD), R&D
By Team Ayurved Sutra
Posted on
